SeaStar Medical Holding Corp (ICU)

Currency in USD
3.860
+0.110(+2.93%)
Closed·
3.939+0.079(+2.04%)
·
ICU is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.6904.000
52 wk Range
0.24213.399
Key Statistics
Prev. Close
3.75
Open
3.79
Day's Range
3.69-4
52 wk Range
0.242-13.399
Volume
73.63K
Average Vol. (3m)
145.4K
1-Year Change
-69.8438%
Book Value / Share
2.89
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ICU Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9.000
Upside
+133.16%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

SeaStar Medical Holding Corp Earnings Call Summary for Q4/2025

  • Q4 2025 revenue surged 370% YoY to $315K; full-year revenue reached $1.1M vs. $135K in 2024, driven by QUELIMMUNE pediatric AKI product sales.
  • Gross profit margin exceeded 90% while operating expenses fell 29% to $3.4M; net loss narrowed 34% YoY to $2.9M in Q4 2025.
  • Company expanded QUELIMMUNE to 16 pediatric hospitals; targets $2M revenue in 2026, doubling 2025 performance.
  • Plans to reach 15 additional top-ranked children's medical centers in 2026, aiming for top 50 U.S. pediatric hospitals.
  • Stock gained 0.45% to $2.25 in aftermarket trading; $8.4M market cap with InvestingPro flagging shares as undervalued.
Last Updated: 03/25/2026, 05:42 PM
Read Full Transcript

Compare ICU to Peers and Sector

Metrics to compare
ICU
Peers
Sector
Relationship
P/E Ratio
−1.3x−3.6x−0.5x
PEG Ratio
−0.01−0.160.00
Price / Book
1.5x5.0x2.6x
Price / LTM Sales
12.5x6.6x3.2x
Upside (Analyst Target)
141.9%49.3%45.7%
Fair Value Upside
Unlock3.8%4.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 9.000
(+133.16% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Maxim Group
Buy6.00+55.44%-MaintainFeb 11, 2026

Earnings

Latest Release
Mar 25, 2026
EPS / Forecast
-0.80 / -0.31
Revenue / Forecast
420K / --
EPS Revisions
Last 90 days

ICU Income Statement

People Also Watch

1.2600
DRMA
+0.80%
12.120
UGRO
-4.72%
0.5087
TPET
-0.25%

FAQ

What Is the SeaStar Medical Holding (ICU) Stock Price Today?

The SeaStar Medical Holding stock price today is 3.860 USD.

What Stock Exchange Does SeaStar Medical Holding Trade On?

SeaStar Medical Holding is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for SeaStar Medical Holding?

The stock symbol for SeaStar Medical Holding is "ICU."

What Is the SeaStar Medical Holding Market Cap?

As of today, SeaStar Medical Holding market cap is 15.420M USD.

What Is SeaStar Medical Holding's Earnings Per Share (TTM)?

The SeaStar Medical Holding EPS (TTM) is -5.861.

From a Technical Analysis Perspective, Is ICU a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has SeaStar Medical Holding Stock Split?

SeaStar Medical Holding has split 2 times.

How Many Employees Does SeaStar Medical Holding Have?

SeaStar Medical Holding has 17 employees.

What is the current trading status of SeaStar Medical Holding (ICU)?

As of Apr 16, 2026, SeaStar Medical Holding (ICU) is trading at a price of 3.860 USD, with a previous close of 3.750 USD. The stock has fluctuated within a day range of 3.690 USD to 4.000 USD, while its 52-week range spans from 0.242 USD to 13.399 USD.

What Is SeaStar Medical Holding (ICU) Price Target According to Analysts?

The average 12-month price target for SeaStar Medical Holding is 9.000 USD, with a high estimate of 12 USD and a low estimate of 6 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +133.16% Upside potential.

What Is the ICU Premarket Price?

ICU's last pre-market stock price is 3.900 USD. The pre-market share volume is 410.000, and the stock has decreased by 0.150, or 4.000%.

What Is the ICU After Hours Price?

ICU's last after hours stock price is 3.939 USD, the stock has decreased by 0.079, or 2.040%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.